Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease-Reference-Cited by-同舟云学术

Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease

Published:2022-12 Issue:6 Volume:77 Page:1504-1514
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Pafili Kalliopi^ORCID,Kahl Sabine,Mastrototaro Lucia^ORCID,Strassburger Klaus,Pesta Dominik^ORCID,Herder Christian^ORCID,Pützer Jennifer,Dewidar Bedair,Hendlinger Mona,Granata Cesare^ORCID,Saatmann Nina^ORCID,Yavas Aslihan^ORCID,Gancheva Sofiya,Heilmann Geronimo^ORCID,Esposito Irene^ORCID,Schlensak Matthias,Roden Michael^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference46 articles.

1. Intercellular and interorgan crosstalk through adipocyte extracellular vesicles;Crewe;Rev Endocr Metab Disord,2021

2. Energy metabolism of white adipose tissue and insulin resistance in humans;Bodis;Eur J Clin Invest,2018

3. The integrative biology of type 2 diabetes;Roden;Nature,2019

4. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease;Donnelly;J Clin Invest,2005

5. Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease;Ter Horst;Diabetes Care,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose Tissue Insulin Resistance Correlates with Disease Severity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Cohort Study;The Journal of Pediatrics;2024-11

2. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

3. Incorporating artificial intelligence in portable infrared thermal imaging for the diagnosis and staging of nonalcoholic fatty liver disease;Journal of Biophotonics;2024-08-06

4. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08

5. Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity;Journal of Hepatology;2024-08